Envoke

Leeds-based health technology company Envoke has raised £1.6 million in a VC funding round led by NPIF – Mercia Equity Finance, Finance Yorkshire's Seedcorn Fund, and Foresight Group. The investment will support the company's international expansion, particularly into the Asia-Pacific market, following its development of a virtual laboratory simulation platform used for remote training and equipment maintenance across the healthcare sector.

Summary of transaction details:

• Value: £1.6 million
• Sector: Healthcare & Biotech / Health Technology
• Advisor: N/A
• Key Entities: Envoke (target); NPIF – Mercia Equity Finance, Finance Yorkshire, and Foresight Group (investors)
• Location: Leeds, United Kingdom

Note: This funding round brings Envoke's total capital raised to over £4 million. The investment follows the company's growing traction with major global customers including Bio-Rad, ThermoFisher Scientific, PacBio, and Haemonetics, and is aimed at accelerating international expansion into the Asia-Pacific region, supported by recent contract wins with Hawaii's national blood laboratories and the US-based Mayo Clinic.